Medical Biotechnologies

Medical Biotechnologies is a Russian pharmaceutical and biotechnology company focused on the development and manufacture of high-tech biopharmaceuticals, particularly recombinant proteins and vaccines. The company operates modern production facilities that comply with international GMP standards, enabling the full-cycle production of complex biologics from substance synthesis to finished dosage forms. Its commercial portfolio includes various interferon-based products and erythropoietins used in the treatment of viral infections, multiple sclerosis, and oncology-related anemia. Medical Biotechnologies plays a significant role in the Russian import substitution program for essential medicines and collaborates with national research institutes to advance its clinical pipeline.